Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
South Korea
· Delayed Price · Currency is KRW 642.00
-7.00 (-1.08%)
At close: Mar 21, 2025, 3:30 PM KST
Kyung Nam Pharm Revenue
In the year 2024, Kyung Nam Pharm had annual revenue of 60.79B KRW with 2.51% growth. Kyung Nam Pharm had revenue of 16.09B in the quarter ending December 31, 2024, with 3.22% growth.
Revenue
60.79B
Revenue Growth
+2.51%
P/S Ratio
0.46
Revenue / Employee
265.47M
Employees
229
Market Cap
50.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60.79B | 1.49B | 2.51% |
| Dec 31, 2023 | 59.30B | 303.06M | 0.51% |
| Dec 31, 2022 | 59.00B | -5.62B | -8.70% |
| Dec 31, 2021 | 64.62B | -6.31B | -8.89% |
| Dec 31, 2020 | 70.93B | 26.13B | 58.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |